Technology
The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after the procedure;…
Quiz Time
Which of the following is an advantage of a dry-suction chest drainage system? a. Lower levels of suction pressure b. Variable bubbling, which indicates…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe…
FDA announces import of injectable drugs used in TPN to ease shortage
On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be imported into…
FDA approves Diclegis for pregnant women who have nausea and vomiting
On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and…
FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana has been…
Virtual visiting: The next best thing to being there
The author explains how virtual visiting helps keep patients connected with loved ones around the country or even the world.
Deep-brain stimulation: Hope for dystonia patients
Deep-brain stimulation can make a significant difference in the lives of patients with dystonia.
Maximize your reprocessing program
Reprocessing can help an organization save money and protect the environment.
How to identify atrioventricular blocks
These arrhythmias can be tricky to interpret on a rhythm strip. The author guides you through the basics.
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia (pain during…
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed…
Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection
The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after…
Quiz Time
Which of the following is an advantage of a dry-suction chest drainage system? a. Lower levels of suction pressure b. Variable bubbling,…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate…
FDA announces import of injectable drugs used in TPN to ease shortage
On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be…
FDA approves Diclegis for pregnant women who have nausea and vomiting
On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing…
FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana…
Virtual visiting: The next best thing to being there
The author explains how virtual visiting helps keep patients connected with loved ones around the country or even the world.
Deep-brain stimulation: Hope for dystonia patients
Deep-brain stimulation can make a significant difference in the lives of patients with dystonia.
Maximize your reprocessing program
Reprocessing can help an organization save money and protect the environment.
How to identify atrioventricular blocks
These arrhythmias can be tricky to interpret on a rhythm strip. The author guides you through the basics.
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia…
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease…
Poll




NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.






